Asha

    Asha means Hope. Asha’s vision is to bring hope in the lives of patients by enhancing the bioavailability of new drugs, helping them get to the market faster and reducing drug development costs. We work with our clients through the solid form screening and selection process. Our innovative and efficient proprietary workflows help discover new solid forms (polymorphs, salts and cocrystals) of pharmaceutical molecules and enhance bioavailability of poorly soluble drugs. We aspire to be the best in class solid form research company in the world.

    RECENT ARTICLES

    DRUG DISCOVERY RESOURCES

    JOIN SUBSCRIBERS from

    • Johnson & Johnson
    • Roche
    • Pfizer
    • Novartis
    • Bayer
    • Merck
    • Sanofi
    • GlaxoSmithKline
    • AbbVie
    • Eli Lilly
    • Boehringer Ingelheim
    • Amgen
    • Bristol-Myers Squibb
    • Gilead
    • AstraZeneca
    • Teva
    • Novo Nordisk
    • Merck KGaA
    • Takeda
    • Celgene (BMS)
    • Biogen
    • Astellas
    • Daiichi Sankyo
    • Regeneron
    • UCB
    • Eisai
    • Servier
    • Kyowa Kirin
    • Shionogi
    • Vertex
    • Lundbeck
    • Taisho
    • Ono
    • Seagen
    • Incyte
    • LEO Pharma
    • Janssen
    • Galapagos
    • Idorsia
    • Astex
    • Arvinas
    • Kymera
    • Relay
    • Schrodinger
    • Mirati
    • Revolution
    • Nimbus
    • Plexxikon
    • Forma
    • Arcus
    • RA Capital
    • ARCH Venture Partners
    • MPM Capital
    • Orbimed
    • The Column Group
    • 5AM Ventures
    • Versant Ventures
    • Deerfield
    • Goldman Sachs
    • Citi
    • Piper Sandler
    • Softbank
    • …and hundreds of others